Form 4 for BBIO BridgeBio Pharma, Inc.
Accepted 2025-05-09 00:00:00 ET · period of report 2025-05-07 · accession 0000950170-25-068335 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-05-09 | 2025-05-07+ | BBIO | MCCORMICK FRANK | Dir | G - Gift | $0.00 | -36.0K | 79.7K | -31% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-08 | G | D | 3,000 | $0.00 | 76,686 | D | — | — | |
| 2 | Common | Common Stock | 2025-05-07 | G | D | 33,000 | $0.00 | 79,686 | D | — | — |